Summarized by Masters of Longevity from Science Daily - Health & Medicine.
Reports a human-based study identifying a natural pathway that limits inflammation by shifting monocyte fate and speeding pain resolution after induced inflammation.
Key Takeaways
- Blocking soluble epoxide hydrolase increased epoxy-oxylipin levels and accelerated pain resolution in treated volunteers.
- Treatment sharply reduced intermediate monocyte numbers in blood and tissue, cells linked to persistent inflammation.
- Findings were confirmed in lab experiments and with a p38 blocker, supporting a conserved mechanism across models.
